Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 21, 2018; 24(27): 3038-3054
Published online Jul 21, 2018. doi: 10.3748/wjg.v24.i27.3038
Published online Jul 21, 2018. doi: 10.3748/wjg.v24.i27.3038
Table 2 Hepatitis C antibody prevalence evidence gap mapping with quality assessment, Arab Peninsula
Bahrain | Kuwait | Oman | Qatar | Saudi Arabia | United Arab Emirates | Yemen | |
Blood donors | No data | 0.8%-1.2% (nationals) (2002) 5.4%-13.5% (migrants) (2002)1 | 0.4%-0.7% (2006-2011)1 | 1.1% (nationals and migrants) 0.5%(nationals) (-)2 | 0.0%-5.6% (nationals and migrants, 1988-2009) 0.4%-4.2% (nationals, 1990-2009) 0.0%-34.0% (migrant, 1990-2002)1 | 0.5%-1.1% (2004-2009)1 | 1.7% (2005)1 |
Pregnant women | No data | No data | No data | No data | 0.1%-4.6% (1989-2002)1 | 13.0%-13.4% (migrants) (1994-1996)1 | 3.3%-8.5% (2011)1 |
Children | No data | No data | No data | No data | 0.7%-1.8% (1989-2002)1 | No data | 2.1% (2007-2009)1 |
Hemodialysis, renal dialysis, and/or dialysis patients | 9.2% (-)3 | 27.0%-71.0% (1992-1995)1 | 26.5% (1991)1 | 44.6% (-)2 | 14.7%-78.2% (1995-2008)1 | 24.4% (1991-1993)1 | 40.0%-62.7% (1997-2013)1 |
Hemophiliac or other bleeding disorder patients | 60.0% (1992)2 | No data | No data | No data | 78.6% (-)3 | No data | No data |
Transfused patients | No data | No data | No data | No data | 4.6%-78.6% (1990-2011)1 | No data | No data |
Thalassemic patients | No data | 33.0% (1965-1995)1 | No data | No data | 12.7%-70.0% (1990-2000)1 | 18.8% (1990-2001)2 | No data |
Patients with hepatocellular carcinoma | No data | No data | No data | No data | 48.5% (2006-2008)1 | No data | 28.4%-38.2% (2001-2010)1 |
Patients with acute liver disease | No data | No data | No data | No data | 3.4%-40.7% (2000-2005)1 | 1.2% (2006-2007)1 | 6.4%-8.8% (1997-1999)1 |
Patients with chronic liver disease | No data | 37.8% (-)2 | No data | 29.4 (2000-2005)1 | 11.9%-65.0% (1989-2004)1 | 43.7% (-)2 | 33.8% (-)3 |
Healthcare workers | No data | 0.9% (-)2 | 0.0% (-)2 | No data | 0.0%-0.3% (2001-2005)1 | No data | 1.1%-3.5% (-)3 |
Barbers | No data | No data | No data | No data | No data | No data | No data |
Contact of patients with hepatitis C | No data | No data | No data | No data | 0.0%-1.6% (-)2 | 27.0% (1994-1996)1 | No data |
People who inject drugs | No data | No data | 48.1% (2011)1 | No data | 14.4%-54.7% (1995-2004)1 | No data | No data |
Prisoners | No data | No data | No data | No data | No data | No data | No data |
Patients with HIV and/or other sexually transmitted infection | No data | 0.9%(2012)1 | No data | No data | 12.0%-15.9% (1985-2010)1 | No data | No data |
Sex workers | No data | No data | No data | No data | No data | No data | No data |
Men who have sex with men | No data | No data | No data | No data | No data | No data | No data |
- Citation: Chaabna K, Cheema S, Abraham A, Alrouh H, Lowenfels AB, Maisonneuve P, Mamtani R. Systematic overview of hepatitis C infection in the Middle East and North Africa. World J Gastroenterol 2018; 24(27): 3038-3054
- URL: https://www.wjgnet.com/1007-9327/full/v24/i27/3038.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i27.3038